119 related articles for article (PubMed ID: 22569075)
21. Faecal occult blood testing in areas of high incidence and mortality; the effect of screening the population aged 50 to 59.
Fisher R; Rooney PS
Colorectal Dis; 2011 Sep; 13(9):1024-9. PubMed ID: 20626761
[TBL] [Abstract][Full Text] [Related]
22. The positive predictive value of guaiac faecal occult blood test in relation to the number of positive squares in two consecutive rounds of colorectal cancer screening.
Manfredi S; Philip J; Campillo B; Piette C; Durand G; Riou F; Bretagne JF
Eur J Cancer Prev; 2011 Jul; 20(4):277-82. PubMed ID: 21633201
[TBL] [Abstract][Full Text] [Related]
23. Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK
Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
[TBL] [Abstract][Full Text] [Related]
24. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
25. Impact of cumulative experience on the quality of screening colonoscopy: A 13-year observational study.
Naumann DN; Kavanagh C; Hipkiss G; Potter-Concannon S; Budhoo M; Ahmed M; Karandikar S
J Med Screen; 2021 Dec; 28(4):433-438. PubMed ID: 33866887
[TBL] [Abstract][Full Text] [Related]
26. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
27. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
Nnoaham KE; Lines C
Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
[TBL] [Abstract][Full Text] [Related]
28. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
[TBL] [Abstract][Full Text] [Related]
29. Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort.
Leen R; Seng-Lee C; Holleran G; O'Morain C; McNamara D
Eur J Gastroenterol Hepatol; 2014 May; 26(5):514-8. PubMed ID: 24699725
[TBL] [Abstract][Full Text] [Related]
30. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
[TBL] [Abstract][Full Text] [Related]
32. Symptoms do not predict colorectal cancer in an FOB screened population.
Saldanha JD; Moug SJ; Linton K; Diament RH
Scott Med J; 2013 May; 58(2):95-8. PubMed ID: 23728754
[TBL] [Abstract][Full Text] [Related]
33. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
[TBL] [Abstract][Full Text] [Related]
34. Screening for colorectal cancer in Italy: 2005 survey.
Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
[TBL] [Abstract][Full Text] [Related]
35. [Colorectal cancer screening programme in Aragon (Spain): preliminary results].
Solé Llop ME; Cano Del Pozo M; García Montero JI; Carrera-Lasfuentes P; Lanas Á
Gac Sanit; 2018; 32(6):559-562. PubMed ID: 28784304
[TBL] [Abstract][Full Text] [Related]
36. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
37. Narrow band imaging vs. high definition colonoscopy for detection of colorectal adenomas in patients with positive faecal occult blood test: a randomised trial.
Senore C; Reggio D; Musso A; Bruno M; De Angelis C; Giordanino C; Coppo C; Tari R; Pagliarulo M; Carmagnola S; Montino F; Silvani M; Segnan N; Rizzetto M; Saracco GM
Dig Liver Dis; 2014 Sep; 46(9):803-7. PubMed ID: 24908572
[TBL] [Abstract][Full Text] [Related]
38. Longer mean colonoscopy withdrawal time is associated with increased adenoma detection: evidence from the Bowel Cancer Screening Programme in England.
Lee TJ; Blanks RG; Rees CJ; Wright KC; Nickerson C; Moss SM; Chilton A; Goddard AF; Patnick J; McNally RJ; Rutter MD
Endoscopy; 2013; 45(1):20-6. PubMed ID: 23254403
[TBL] [Abstract][Full Text] [Related]
39. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
[TBL] [Abstract][Full Text] [Related]
40. Randomised study of screening for colorectal cancer with faecal-occult-blood test.
Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
Lancet; 1996 Nov; 348(9040):1467-71. PubMed ID: 8942774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
